DHNasdaqServices-Prepackaged SoftwareUS GAAP · USD

Definitive Healthcare Corp.

Definitive Healthcare Corp. sells subscription-based healthcare commercial intelligence software that helps companies find markets, prospects, and decision-makers across the U.S. healthcare ecosystem. Its platform combines provider, claims, consumer, and market data with analytics and workflow tools for life sciences, provider, and diversified healthcare customers.

Revenue242m USD
−4.2 %y/y
Operating profit (EBIT)-224m USD
+68.4 %y/y
EBIT margin-92.9%
+189.0 ppy/y
Net income-139m USD
+66.4 %y/y
Free cash flow37.1m USD
−19.2 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-800-600-400-2000200400m USD2020: 118 m USD2020: EBIT -14 m USD20202021: 166 m USD2021: EBIT -25 m USD20212022: 223 m USD2022: EBIT -44 m USD20222023: 251 m USD2023: EBIT -330 m USD20232024: 252 m USD2024: EBIT -711 m USD20242025: 242 m USD2025: EBIT -224 m USD2025242-224
RevenueOperating profit (EBIT)

Business

Share of revenue
Healthcare data platform subscriptions96 %

Core SaaS subscriptions giving customers access to healthcare ecosystem data, analytics, and workflow tools.

Claims and consumer analytics2 %

Modeled claims and consumer datasets used to target, message, and engage healthcare audiences.

Professional services and other2 %

Implementation, support, and other non-subscription services tied to platform usage.

Products

Reported · share of revenue
96.2%FY2025100 %
  • Subscription Services96.2 %
  • Professional Services3.8 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

Customers are companies that buy paid subscriptions to use Definitive Healthcare’s data and analytics platform. The main end markets are life sciences, providers, and diversified healthcare-related businesses, with users spanning sales, marketing, clinical research, product development, strategy, and physician network management. The platform is bought because it helps customers identify opportunities, target decision-makers, and improve commercial execution in a complex healthcare market.

Life Sciences

Biopharmaceutical and medical device companies buy data to support product development, market entry, targeting, and sales execution.

Provider

Hospitals, health systems, and care delivery organizations use the platform to understand provider networks, markets, and referral opportunities.

Diversified healthcare

Healthcare IT, staffing, real estate, financial services, and marketing firms use the data to sell into the healthcare ecosystem.

Commercial teams

Sales and marketing users buy access to decision-maker and account intelligence to improve outreach and conversion.

Strategy and research teams

Corporate strategy, clinical research, and product teams use the platform for market sizing and opportunity analysis.

Strategy

Management is focused on expanding the platform with new intelligence modules, analytics, workflow capabilities, and additional data sources. The company is also investing in AI and machine learning to deepen data linkages and maintain a differentiated dataset, while selectively pursuing acquisitions such as Carevoyance to broaden the product set.

Expand product breadth and use casesMedium term

More modules and workflows increase customer value and raise switching costs.

Improve data quality and proprietary linkagesShort term

A richer, more connected dataset is the main source of differentiation in a fragmented market.

Defend renewals and manage deal-cycle pressureShort term

Subscription revenue depends on retention and timely renewals, which are pressured by macro conditions.

Geography

2025

The business is centered on the U.S. healthcare ecosystem, and the company describes its products as providing comprehensive information on the U.S. market. It does not disclose a meaningful country revenue split in the provided excerpts, so the geographic profile should be viewed as U.S.-centric rather than globally diversified. Headquarters are in Framingham, Massachusetts, and the company operates through Definitive OpCo and its subsidiaries.

United States93 %
Other countries (US filing)7.1 %

Share of the revenue the company reports by geography.

Risks

The company is highly dependent on subscription demand, so slower healthcare spending or longer customer approval cycles can directly reduce renewals and new bookings. It also relies on third-party data and cloud infrastructure, which creates supply-chain, cybersecurity, and data-availability risk; changes in claims data sourcing and pricing could affect product quality and margins. The TRA structure and debt covenants add financial and governance complexity, while goodwill, acquired technology, and data assets create impairment and amortization risk.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Subscription demand slowdown1Macroeconomic pressure on customer buying cycles2Third-party data source disruption3Cybersecurity and supply-chain incidents4TRA and debt-related cash obligations5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Subscription demand slowdownImpact: HighLikelihood: High

    Nearly all revenue comes from subscriptions, so weaker demand directly affects growth and retention.

    Exposure: 96% of revenue from subscription services

  2. Macroeconomic pressure on customer buying cyclesImpact: HighLikelihood: High

    Customers are taking longer to approve purchases and renewals, which can defer revenue.

    Exposure: New sales and renewals

  3. Third-party data source disruptionImpact: HighLikelihood: Medium

    The platform depends on external claims and other data sources; pricing or access changes can hurt margins and product completeness.

    Exposure: Claims data market

  4. Cybersecurity and supply-chain incidentsImpact: MediumLikelihood: Medium

    Outsourced infrastructure and third-party vendors increase the attack surface and operational interruption risk.

    Exposure: Cloud and vendor ecosystem

  5. TRA and debt-related cash obligationsImpact: MediumLikelihood: Medium

    Tax receivable agreement payments and covenant restrictions can reduce financial flexibility.

    Exposure: Cash distributions and leverage structure

Accounting

Judgemental items
Revenue recognition for subscriptions

Most revenue comes from access to the SaaS platform, so contract timing affects quarterly revenue and deferred revenue.

Impact: Affects revenue timing, deferred revenue, and RPO

Capitalized acquired technology and data

Acquisitions add amortizable assets that can increase non-cash expense and affect margins.

Impact: Affects operating income and EBITDA bridge

Goodwill and intangible impairment

The business relies on acquired and internally developed data assets that may be impaired if growth slows.

Impact: Could create large non-cash charges

Tax receivable agreement

The structure requires cash payments tied to tax benefits, which can be substantial.

Impact: Affects cash flow and balance sheet liabilities

Debt extinguishment and covenant accounting

Refinancing and partial repayments can create one-time losses and covenant constraints.

Impact: Affects non-operating expense and liquidity

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026